Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7701 - 7725 of 8109 in total
A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
Withdrawn
JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia, Smoking Cessation, Cognition Disorders, and Alzheimer's Disease.
Investigational
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational
Onatasertib (CC-223) has been used in trials studying the treatment and basic science of Multiple Myeloma, Glioblastoma Multiforme, HepatoCellular Carcinoma, Non-small Cell Lung Cancer, and Diffuse Large B-Cell Lymphoma, among others.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Cafedrine is under investigation in clinical trial NCT01311414 (Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation).
Investigational
IPI-493 has been used in trials studying the treatment of Advanced Malignancies.
Investigational
Delpazolid (LCB01-0371) is under investigation in clinical trial NCT01554995 (A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study).
Investigational
Bamifylline is a selective A1 adenosine receptor antagonist.
Experimental
Tiazofurine has potential clinical use in cancer treatment as it is a potential inhibitor of Inosine- 5’-monophosphate (IMP) dehydrogenase .
Experimental
Experimental
Experimental
PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations In Healthy Volunteers).
Investigational
Displaying drugs 7701 - 7725 of 8109 in total